Shandong Xinhua Pharmaceutical Co Ltd
SZSE:000756
Shandong Xinhua Pharmaceutical Co Ltd
SZSE:000756
Price:
15.73
CNY
Market Closed
Market Cap:
¥10.9B
Relative Value
The Relative Value of one
Shandong Xinhua Pharmaceutical Co Ltd
stock under the Base Case scenario is
19.59
CNY.
Compared to the current market price of 15.73 CNY,
Shandong Xinhua Pharmaceutical Co Ltd
is
Undervalued by 20%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Relative Value
Base Case
19.59
CNY
Undervaluation 20%
Multiples Across Competitors
Competitors Multiples
Shandong Xinhua Pharmaceutical Co Ltd Competitors
Shandong Xinhua Pharmaceutical Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
|
Shandong Xinhua Pharmaceutical Co Ltd
SZSE:000756
|
10.9B CNY | 1.3 | 28.4 | 23.1 | 23.1 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
987B USD | 15.1 | 47.8 | 32.2 | 34.3 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
592.7B USD | 6.3 | 22.1 | 15.3 | 18.9 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
297.3B CHF | 4.8 | 31.5 | 13.3 | 15.5 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
236.7B GBP | 5.4 | 31.2 | 17.3 | 24.4 | |
| CH |
|
Novartis AG
SIX:NOVN
|
247.2B CHF | 5.7 | 22.8 | 14.1 | 18.1 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
309B USD | 4.8 | 16.9 | 10.6 | 12.4 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 344.9 | 865 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.4 | 10.4 | 7.7 | 9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
154.4B USD | 2.5 | 19.9 | 7.4 | 9.9 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
124.1B USD | 2.6 | 17.6 | 7.4 | 9.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
